Go Pro

Fair Oaks Income 2021 (FAIR) Competitors

Fair Oaks Income 2021 logo
GBX 4.02 0.00 (0.00%)
As of 09:57 AM Eastern

FAIR vs. PU12, CYS, TEK, TV2H, and RTW

Should you buy Fair Oaks Income 2021 stock or one of its competitors? Fair Oaks Income 2021's main competitors and comparable companies include Puma VCT 12 (PU12), Chrysalis VCT (CYS), Tekcapital (TEK), Thames Ventures VCT 2 Healthcare Shs (TV2H), and RTW Biotech Opportunities (RTW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Fair Oaks Income 2021 compare to Puma VCT 12?

Puma VCT 12 (LON:PU12) and Fair Oaks Income 2021 (LON:FAIR) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

In the previous week, Puma VCT 12's average media sentiment score of 0.00 equaled Fair Oaks Income 2021'saverage media sentiment score.

Company Overall Sentiment
Puma VCT 12 Neutral
Fair Oaks Income 2021 Neutral

Puma VCT 12 pays an annual dividend of GBX 0.03 per share. Fair Oaks Income 2021 pays an annual dividend of GBX 79.84 per share and has a dividend yield of 1,986.2%. Puma VCT 12 pays out 17.6% of its earnings in the form of a dividend. Fair Oaks Income 2021 pays out 283.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

23.1% of Fair Oaks Income 2021 shares are owned by institutional investors. 0.2% of Fair Oaks Income 2021 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Fair Oaks Income 2021 has a net margin of 97.31% compared to Puma VCT 12's net margin of 0.00%. Fair Oaks Income 2021's return on equity of 14.04% beat Puma VCT 12's return on equity.

Company Net Margins Return on Equity Return on Assets
Puma VCT 12N/A N/A N/A
Fair Oaks Income 2021 97.31%14.04%N/A

Fair Oaks Income 2021 has higher revenue and earnings than Puma VCT 12. Puma VCT 12 is trading at a lower price-to-earnings ratio than Fair Oaks Income 2021, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Puma VCT 12£5.99M0.00N/A£0.17N/A
Fair Oaks Income 2021£12.71M0.18£2.91B£28.200.14

Summary

Fair Oaks Income 2021 beats Puma VCT 12 on 7 of the 9 factors compared between the two stocks.

How does Fair Oaks Income 2021 compare to Chrysalis VCT?

Chrysalis VCT (LON:CYS) and Fair Oaks Income 2021 (LON:FAIR) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Fair Oaks Income 2021 has a net margin of 97.31% compared to Chrysalis VCT's net margin of 0.00%. Fair Oaks Income 2021's return on equity of 14.04% beat Chrysalis VCT's return on equity.

Company Net Margins Return on Equity Return on Assets
Chrysalis VCTN/A N/A N/A
Fair Oaks Income 2021 97.31%14.04%N/A

In the previous week, Chrysalis VCT's average media sentiment score of 0.00 equaled Fair Oaks Income 2021'saverage media sentiment score.

Company Overall Sentiment
Chrysalis VCT Neutral
Fair Oaks Income 2021 Neutral

23.1% of Fair Oaks Income 2021 shares are owned by institutional investors. 0.2% of Fair Oaks Income 2021 shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Chrysalis VCT pays an annual dividend of GBX 0.05 per share. Fair Oaks Income 2021 pays an annual dividend of GBX 79.84 per share and has a dividend yield of 1,986.2%. Chrysalis VCT pays out 10.0% of its earnings in the form of a dividend. Fair Oaks Income 2021 pays out 283.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Fair Oaks Income 2021 has higher revenue and earnings than Chrysalis VCT. Chrysalis VCT is trading at a lower price-to-earnings ratio than Fair Oaks Income 2021, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chrysalis VCT£789K0.00N/A£0.50N/A
Fair Oaks Income 2021£12.71M0.18£2.91B£28.200.14

Summary

Fair Oaks Income 2021 beats Chrysalis VCT on 7 of the 9 factors compared between the two stocks.

How does Fair Oaks Income 2021 compare to Tekcapital?

Tekcapital (LON:TEK) and Fair Oaks Income 2021 (LON:FAIR) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Fair Oaks Income 2021 has higher revenue and earnings than Tekcapital. Tekcapital is trading at a lower price-to-earnings ratio than Fair Oaks Income 2021, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tekcapital£281.86K31.02£19.73M-£10.00N/A
Fair Oaks Income 2021£12.71M0.18£2.91B£28.200.14

Tekcapital has a beta of 0.882, suggesting that its share price is 12% less volatile than the broader market. Comparatively, Fair Oaks Income 2021 has a beta of 0.09128701, suggesting that its share price is 91% less volatile than the broader market.

0.8% of Tekcapital shares are held by institutional investors. Comparatively, 23.1% of Fair Oaks Income 2021 shares are held by institutional investors. 4.4% of Tekcapital shares are held by company insiders. Comparatively, 0.2% of Fair Oaks Income 2021 shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tekcapital has a net margin of 43,011.88% compared to Fair Oaks Income 2021's net margin of 97.31%. Tekcapital's return on equity of 93.86% beat Fair Oaks Income 2021's return on equity.

Company Net Margins Return on Equity Return on Assets
Tekcapital43,011.88% 93.86% 14.01%
Fair Oaks Income 2021 97.31%14.04%N/A

In the previous week, Tekcapital had 1 more articles in the media than Fair Oaks Income 2021. MarketBeat recorded 1 mentions for Tekcapital and 0 mentions for Fair Oaks Income 2021. Tekcapital's average media sentiment score of 0.13 beat Fair Oaks Income 2021's score of 0.00 indicating that Tekcapital is being referred to more favorably in the media.

Company Overall Sentiment
Tekcapital Neutral
Fair Oaks Income 2021 Neutral

Summary

Tekcapital beats Fair Oaks Income 2021 on 8 of the 13 factors compared between the two stocks.

How does Fair Oaks Income 2021 compare to Thames Ventures VCT 2 Healthcare Shs?

Fair Oaks Income 2021 (LON:FAIR) and Thames Ventures VCT 2 Healthcare Shs (LON:TV2H) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, Fair Oaks Income 2021's average media sentiment score of 0.00 equaled Thames Ventures VCT 2 Healthcare Shs'average media sentiment score.

Company Overall Sentiment
Fair Oaks Income 2021 Neutral
Thames Ventures VCT 2 Healthcare Shs Neutral

Fair Oaks Income 2021 has a net margin of 97.31% compared to Thames Ventures VCT 2 Healthcare Shs' net margin of 0.00%. Fair Oaks Income 2021's return on equity of 14.04% beat Thames Ventures VCT 2 Healthcare Shs' return on equity.

Company Net Margins Return on Equity Return on Assets
Fair Oaks Income 202197.31% 14.04% N/A
Thames Ventures VCT 2 Healthcare Shs N/A N/A N/A

Fair Oaks Income 2021 has higher revenue and earnings than Thames Ventures VCT 2 Healthcare Shs. Thames Ventures VCT 2 Healthcare Shs is trading at a lower price-to-earnings ratio than Fair Oaks Income 2021, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fair Oaks Income 2021£12.71M0.18£2.91B£28.200.14
Thames Ventures VCT 2 Healthcare ShsN/AN/AN/A-£0.02N/A

23.1% of Fair Oaks Income 2021 shares are held by institutional investors. 0.2% of Fair Oaks Income 2021 shares are held by insiders. Comparatively, 0.1% of Thames Ventures VCT 2 Healthcare Shs shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Fair Oaks Income 2021 pays an annual dividend of GBX 79.84 per share and has a dividend yield of 1,986.2%. Thames Ventures VCT 2 Healthcare Shs pays an annual dividend of GBX 1 per share. Fair Oaks Income 2021 pays out 283.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Thames Ventures VCT 2 Healthcare Shs pays out -5,000.0% of its earnings in the form of a dividend.

Summary

Fair Oaks Income 2021 beats Thames Ventures VCT 2 Healthcare Shs on 8 of the 9 factors compared between the two stocks.

How does Fair Oaks Income 2021 compare to RTW Biotech Opportunities?

Fair Oaks Income 2021 (LON:FAIR) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

RTW Biotech Opportunities has higher revenue and earnings than Fair Oaks Income 2021. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Fair Oaks Income 2021, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fair Oaks Income 2021£12.71M0.18£2.91B£28.200.14
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

RTW Biotech Opportunities has a net margin of 158.61% compared to Fair Oaks Income 2021's net margin of 97.31%. RTW Biotech Opportunities' return on equity of 36.01% beat Fair Oaks Income 2021's return on equity.

Company Net Margins Return on Equity Return on Assets
Fair Oaks Income 202197.31% 14.04% N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

Fair Oaks Income 2021 has a beta of 0.09128701, indicating that its stock price is 91% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market.

23.1% of Fair Oaks Income 2021 shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 0.2% of Fair Oaks Income 2021 shares are owned by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Fair Oaks Income 2021's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Fair Oaks Income 2021 Neutral
RTW Biotech Opportunities Neutral

Summary

RTW Biotech Opportunities beats Fair Oaks Income 2021 on 7 of the 11 factors compared between the two stocks.

Get Fair Oaks Income 2021 News Delivered to You Automatically

Sign up to receive the latest news and ratings for FAIR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FAIR vs. The Competition

MetricFair Oaks Income 2021Capital Markets IndustryFinance SectorLON Exchange
Market Cap£2.34M£5.72B£14.01B£2.92B
Dividend Yield15.31%7.39%5.89%6.17%
P/E Ratio0.1432.5326.67367.32
Price / Sales0.181,212.73513.1583,333.24
Price / CashN/A48.4239.1427.89
Price / Book0.072.152.196.97
Net Income£2.91B£417.46M£1.31B£5.89B
7 Day Performance0.50%0.58%1.01%0.74%
1 Month Performance1.52%2.27%2.23%3.34%
1 Year Performance652.81%7.84%11.51%23.04%

Fair Oaks Income 2021 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FAIR
Fair Oaks Income 2021
N/AGBX 4.02
flat
N/A+670.1%£2.34M£12.71M0.14N/A
PU12
Puma VCT 12
N/AN/AN/AN/A£9.25M£5.99M141.18N/A
CYS
Chrysalis VCT
N/AN/AN/AN/A£9.25M£789K65.0017
TEK
Tekcapital
N/AGBX 3.57
-0.8%
N/A-50.9%£9.18M£281.86KN/A6
TV2H
Thames Ventures VCT 2 Healthcare Shs
N/AN/AN/AN/A£8.83MN/AN/AN/A

Related Companies and Tools


This page (LON:FAIR) was last updated on 8/28/2026 by MarketBeat.com Staff.
From Our Partners